4.5 Article

Regulation of Nucleocytoplasmic Shuttling of Bruton's Tyrosine Kinase (Btk) through a Novel SH3-Dependent Interaction with Ankyrin Repeat Domain 54 (ANKRD54)

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 32, Issue 13, Pages 2440-2453

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.06620-11

Keywords

-

Funding

  1. Erik Edith Fernstrom Stiftelse
  2. Sodertorn University-College
  3. COMSATS, Institute of Information-Technology, Islamabad, Pakistan
  4. MoHE in the Kurdistan Regional Government, Iraq
  5. Swedish Cancer Society
  6. Swedish Research Council
  7. Stockholm County Council
  8. European Council

Ask authors/readers for more resources

Bruton's tyrosine kinase (Btk), belonging to the Tec family of tyrosine kinases (TFKs), is essential for B-lymphocyte development. Abrogation of Btk signaling causes human X-linked agammaglobulinemia (XLA) and murine X-linked immunodeficiency (Xid). We employed affinity purification of Flag-tagged Btk, combined with tandem mass spectrometry, to capture and identify novel interacting proteins. We here characterize the interaction with ankryin repeat domain 54 protein (ANKRD54), also known as Lyn-interacting ankyrin repeat protein (Liar). While Btk is a nucleocytoplasmic protein, the Liar pool was found to shuttle at a higher rate than Btk. Importantly, our results suggest that Liar mediates nuclear export of both Btk and another TFK, Txk/Rlk. Liar-mediated Btk shuttling was enriched for activation loop, nonphosphorylated Btk and entirely dependent on Btk's SH3 domain. Liar also showed reduced binding to an aspartic acid phosphomimetic SH3 mutant. Three other investigated nucleus-located proteins, Abl, estrogen receptor beta (ER beta), and transcription factor T-bet, were all unaffected by Liar. We mapped the interaction site to the C terminus of the Btk SH3 domain. A biotinylated, synthetic Btk peptide, ARDKNGQEGYIPSNYVTEAEDS, was sufficient for this interaction. Liar is the first protein identified that specifically influences the nucleocytoplasmic shuttling of Btk and Txk and belongs to a rare group of known proteins carrying out this activity in a Crm1-dependent manner.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib

H. Yesid Estupinan, Qing Wang, Anna Berglof, Gerard C. P. Schaafsma, Yuye Shi, Litao Zhou, Dara K. Mohammad, Liang Yu, Mauno Vihinen, Rula Zain, C. I. Edvard Smith

Summary: Certain double mutants were found to be super-resistant to irreversible inhibitors, while reversible inhibitors showed variable patterns from resistance to no resistance, collectively demonstrating the structural constraints for different classes of inhibitors that may affect their clinical application.

LEUKEMIA (2021)

Review Cell Biology

Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects

H. Yesid Estupinan, Anna Berglof, Rula Zain, C. I. Edvard Smith

Summary: BTK inhibitors have shown efficacy in treating B-cell tumors, but are increasingly being tested for autoimmune diseases and inflammation. Adverse effects such as cardiovascular issues and bleeding can persist, while skin manifestations and diarrhea may occur early but subside.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System

Tea Umek, Thomas Olsson, Olof Gissberg, Osama Saher, Eman M. Zaghloul, Karin E. Lundin, Jesper Wengel, Eric Hanse, Henrik Zetterberg, Dzeneta Vizlin-Hodzic, C. I. Edvard Smith, Rula Zain

Summary: Huntington's disease is a dominantly inherited neurodegenerative disorder that affects the striatum, cerebral cortex, and other subcortical structures. The mutation in the HTT gene leads to the formation of mutant HTT protein aggregates, and reducing both mutant mRNA and protein shows promise as a treatment strategy.

NUCLEIC ACID THERAPEUTICS (2021)

Article Oncology

Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients

Lisa Blixt, Gordana Bogdanovic, Marcus Buggert, Yu Gao, Sophia Hober, Katie Healy, Hemming Johansson, Christian Kjellander, Sara Mravinacova, Sandra Muschiol, Peter Nilsson, Marzia Palma, Elisa Pin, C. I. Edvard Smith, Olga Stromberg, Margaret Sallberg Chen, Rula Zain, Lotta Hansson, Anders Osterborg

Summary: The study revealed that severe cases of Covid-19 were equally distributed among CLL patients, regardless of age, gender, BMI, or CLL status, except for the Cumulative Illness Rating Scale (CIRS). The mortality rate was higher in patients aged 75 and above. Despite the high hospitalization rate, there was a numerical reduction in deaths and ICU admissions during different periods of the pandemic. Most convalescent patients showed robust and durable B and/or T cell immunity, with a majority testing positive for anti-SARS-CoV-2 antibodies even six to twelve months after infection.

LEUKEMIA (2022)

Article Biochemistry & Molecular Biology

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals

Angelica Cuapio, Caroline Boulouis, Iva Filipovic, David Wullimann, Tobias Kammann, Tiphaine Parrot, Puran Chen, Mira Akber, Yu Gao, Quirin Hammer, Benedikt Strunz, Andre Perez Potti, Olga Rivera Ballesteros, Joshua Lange, Jagadeeswara Rao Muvva, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Soderdahl, Anders Osterborg, C. I. Edvard Smith, Gordana Bogdanovic, Sandra Muschiol, Fredrika Hellgren, Karin Lore, Michal J. Sobkowiak, Giorgio Gabarrini, Katie Healy, Margaret Sallberg Chen, Evren Alici, Niklas K. Bjorkstrom, Marcus Buggert, Per Ljungman, Johan K. Sandberg, Soo Aleman, Hans-Gustaf Ljunggren

Summary: This study characterized NK cells in healthy individuals and immunocompromised patients during the course of an anti-SARS-CoV-2 BNT162b2 mRNA vaccine trial. The results showed that NK cell numbers, frequencies, subsets, phenotypes, and function remained unchanged following vaccination. Furthermore, a positive correlation was observed between the frequency of a specific type of NK cells at baseline and the antibody titers after vaccination.

MOLECULAR MEDICINE (2022)

Article Genetics & Heredity

Clinical measurement of cellular DNA damage hypersensitivity in patients with DNA repair defects

Ola Hammarsten, Anna Lyytikainen, Sofia Thunstrom, Torben Ek, Anders Fasth, Olov Ekwall, Sara Cajander, Emilie Wahren Borgstrom, C. I. Edvard Smith, Pegah Johansson

Summary: This study successfully measured the sensitivity of patient cells to DNA-damaging agents using an in vitro assay and found associations between different DNA repair gene variants and cell sensitivity.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Engineering, Biomedical

Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles

Jeremy P. Bost, Osama Saher, Daniel Hagey, Doste R. Mamand, Xiuming Liang, Wenyi Zheng, Giulia Corso, Oskar Gustafsson, Andre Gorgens, Ci Edvard Smith, Rula Zain, Samir El Andaloussi, Dhanu Gupta

Summary: Extracellular vesicles (EVs) are nanosized cell-derived vesicles that facilitate intercellular communication via transmitting biological cargo. The production of EVs is influenced by various pathways and external factors in the cell media, with ceramide-dependent pathway being a major contributor to engineered EV production. The study provides insights into understanding and optimizing EV production in cell culture for developing advanced methods.

ADVANCED HEALTHCARE MATERIALS (2022)

Review Immunology

Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukaemia?

Carl Inge Edvard Smith, Rula Zain, Anders osterborg, Marzia Palma, Marcus Buggert, Peter Bergman, Yenan Bryceson

Summary: The scarcity of plasmacytoid dendritic cells (pDCs) in patients with chronic lymphocytic leukaemia (CLL) may contribute to the severe clinical course of COVID-19 in these patients. Treatment of CLL with Bruton's tyrosine kinase (BTK) inhibitors can increase the number of pDCs.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

A mechanism of self-lipid endocytosis mediated by the receptor Mincle

Alexey V. Kostarnoy, Petya G. Gancheva, Igor I. Kireev, Andrey I. Soloviev, Bernd Lepenies, Andrey Y. Kulibin, Ekaterina A. Malolina, Olga N. Scheglovitova, Alexey V. Kondratev, Maria V. Sokolova, Daria Vorobyeva, Nadezhda Filippova, Marina R. Kapkaeva, Maria A. Lagarkova, Pavel S. Metalnikova, Evgeniy Riabenko, Daniil A. Grumov, Maxim A. Bobrov, Elena Vasilieva, Boris S. Naroditsky, Alexander L. Gintsburg

Summary: Cellular lipid uptake is a fundamental physiological process, and we have discovered a previously unknown mechanism of lipid cargo uptake mediated by the receptor Mincle. Our study reveals that Mincle tightly binds a range of self-lipids and forms vesicles in the cytoplasm. Knockout of Mincle leads to a significant decrease in lipid endocytosis, suggesting it as a prospective target for disorders of lipid metabolism.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Endocrinology & Metabolism

Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial

Per-Ola Carlsson, Daniel Espes, Sofia Sisay, Lindsay C. Davies, C. I. Edvard Smith, Mathias G. Svahn

Summary: This study aimed to investigate the safety and efficacy of treatment with allogeneic Wharton's jelly-derived mesenchymal stromal cells (MSCs) in recent-onset type 1 diabetes. Results showed that treatment with ProTrans resulted in smaller decline in C-peptide levels and no change in insulin requirements, suggesting the potential to preserve beta cell function.

DIABETOLOGIA (2023)

Article Biochemistry & Molecular Biology

SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiency

Laurent Schmied, Thuy T. Luu, Jonas N. Sondergaard, Sophia H. Hald, Stephan Meinke, Dara K. Mohammad, Sunitha B. Singh, Corinna Mayer, Giovanna Perinetti Casoni, Michael Chrobok, Heinrich Schlums, Giorgia Rota, Hieu M. Truong, Lisa S. Westerberg, Greta Guarda, Evren Alici, Arnika K. Wagner, Nadir Kadri, Yenan T. Bryceson, Mezida B. Saeed, Petter Hoglund

Summary: Natural killer (NK) cells recognize infected cells and tumors. The function of NK cells depends on balanced signaling from activating and inhibitory receptors. The subcellular localization of tyrosine phosphatase SHP-1 determines NK cell tolerance and education. Education of NK cells leads to reduced synapse accumulation of SHP-1 and augmented signaling from activating receptors.

SCIENCE SIGNALING (2023)

Article Biochemistry & Molecular Biology

Assessment of T Cell Receptor Complex Expression Kinetics in Natural Killer Cells

Khder H. Rasul, Alamdar Hussain, Hazel Reilly, Maria Karvouni, Carin I. M. Dahlberg, Mustafa S. Al-Attar, Arnika K. Wagner, Evren Alici, Dara K. Mohammad

Summary: This study investigates the cellular processing of the TCR complex in NK cells. The findings suggest that the absence of CD3 subunits prevents surface expression of the TCR complex in NK cells. Additionally, TCR expression on the surface of NK cells gradually increases after transduction. The TCR complex in NK92 cells is shown to be functional.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)

Article Medicine, Research & Experimental

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals

Katie Healy, Elisa Pin, Puran Chen, Gunnar Soderdahl, Piotr Nowak, Stephan Mielke, Lotta Hansson, Peter Bergman, C. I. Edvard Smith, Per Ljungman, Davide Valentini, Ola Blennow, Anders Osterborg, Giorgio Gabarrini, Khaled Al-Manei, Hassan Alkharaan, Michal Jacek Sobkowiak, Jamil Yousef, Sara Mravinacova, Angelica Cuapio, Xinling Xu, Mira Akber, Karin Lore, Cecilia Hellstrom, Sandra Muschiol, Gordana Bogdanovic, Marcus Buggert, Hans-Gustaf Ljunggren, Sophia Hober, Peter Nilsson, Soo Aleman, Margaret Sallberg Chen

Summary: This study found that the mRNA BNT162b2 vaccine can induce immune responses in the saliva of immunocompromised individuals to SARS-CoV-2 spike antigens. Salivary responses were correlated with specific IgG titers and neutralizing capacity in serum, and had a high predictive power for identifying vulnerable groups for revaccination.
Article Engineering, Biomedical

Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles

Dhanu Gupta, Oscar P. B. Wiklander, Andre Goergens, Mariana Conceicao, Giulia Corso, Xiuming Liang, Yiqi Seow, Sriram Balusu, Ulrika Feldin, Beklem Bostancioglu, Rim Jawad, Doste R. Mamand, Yi Xin Fiona Lee, Justin Hean, Imre Mager, Thomas C. Roberts, Manuela Gustafsson, Dara K. Mohammad, Helena Sork, Alexandra Backlund, Per Lundin, Antonin de Fougerolles, C. I. Edvard Smith, Matthew J. A. Wood, Roosmarijn E. Vandenbroucke, Joel Z. Nordin, Samir El-Andaloussi

Summary: This study optimized the loading of two different therapeutic protein receptors onto extracellular vesicles through genetic engineering and protein moiety screening, leading to alleviation of inflammation-related diseases.

NATURE BIOMEDICAL ENGINEERING (2021)

Article Hematology

Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia

Tom A. Mulder, Lucia Pena-Perez, Anna Berglof, Stephan Meinke, H. Yesid Estupinan, Kia Heimersson, Rula Zain, Robert Mansson, C. I. Edvard Smith, Marzia Palma

Summary: Ibrutinib is highly effective in chronic lymphocytic leukemia, but can cause side effects like atrial fibrillation. During treatment, significant changes in plasma biomarkers and immune cell numbers were observed, with an increase in markers associated with cardiovascular diseases potentially contributing to atrial fibrillation.

HEMASPHERE (2021)

No Data Available